HEALTH● LOWJul 24 · Jul 24, 2026, 12:58 PM
Merck signs licensing deals with companies including Viatris for new HIV pill
Seeking Alpha Tech
Merck has entered into licensing agreements with multiple companies, including Viatris, concerning a new HIV medication.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH48m agoDiphtheria: No outbreak in Lagos – AbayomiVanguard NigeriaHEALTH2h agoEpilepsy pushed under with years - long treatment waitwesternadvocate.com.au · AustraliaHEALTH2h agoAlert for the "Cicada virus" which is already in Argentina: the curious origin of its name and the risk of contagionClarínHEALTH2h agoLassa fever: NCDC identifies preparedness gaps, unveils readiness plan ahead of peak seasonPremium Times